Ticker Launch
Sign inGet notified

IPO · LVTX

LAVA Therapeutics NV

Formerly LAVA Therapeutics BV

LAVA Therapeutics NV (LVTX) priced its initial public offering on Mar 26, 2021 at $15.00 per share, within its $14.00–$16.00 range, raising $100.5M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $380.3M. J.P. Morgan was lead-left underwriter, joined by Jefferies and Leerink Partners. Cooley advised the company and Davis Polk advised the underwriters.

Status
IPO
Ticker
LVTX
Exchange
Nasdaq Global Select
Priced
Mar 26, 2021
IPO price
$15.00
Price range
$14.00–$16.00
Raised
$100.5M
Market cap at IPO price
$380.3M
First filed
Mar 2, 2021
Underwriters
J.P. Morgan, Jefferies and Leerink Partners
Company counsel
Cooley
Underwriters' counsel
Davis Polk
Sector
Biotech & pharma

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Get notified at launchOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other Biotech & pharma IPOs in 2021